Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ARRY Stock Forecast 2026-2027
$8.09
Current Price
$1.24B
Market Cap
Buy 13
Hold 11
Sell 0
Wall St Analyst Ratings
Distance to ARRY Price Targets
+97.8%
To High Target of $16.00
+23.6%
To Median Target of $10.00
-1.1%
To Low Target of $8.00
ARRY Price Momentum
-10.9%
1 Week Change
-0.5%
1 Month Change
+7.9%
1 Year Change
-12.3%
Year-to-Date Change
-33.9%
From 52W High of $12.23
+50.1%
From 52W Low of $5.39
📊 TOP ANALYST CALLS
Did ARRY Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Array BioPharma is one of their latest high-conviction picks.
Latest ARRY Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, ARRY has a bullish consensus with a median price target of $10.00 (ranging from $8.00 to $16.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $8.09, the median forecast implies a 23.6% upside. This outlook is supported by 13 Buy, 11 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ARRY Analyst Ratings
13
Buy
11
Hold
0
Sell
ARRY Price Target Range
Low
$8.00
Average
$10.00
High
$16.00
Current: $8.09
Latest ARRY Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ARRY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2026 | UBS | Jon Windham | Buy | Maintains | $11.00 |
| May 7, 2026 | JP Morgan | Mark Strouse | Overweight | Maintains | $10.00 |
| Apr 21, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Apr 16, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Apr 9, 2026 | Susquehanna | Neutral | Maintains | $N/A | |
| Apr 7, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Mar 2, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Feb 26, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Feb 26, 2026 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Feb 26, 2026 | Deutsche Bank | Hold | Downgrade | $N/A | |
| Jan 14, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Jan 9, 2026 | TD Cowen | Buy | Upgrade | $N/A | |
| Nov 11, 2025 | UBS | Buy | Maintains | $N/A | |
| Nov 11, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Nov 10, 2025 | Seaport Global | Buy | Upgrade | $N/A | |
| Nov 7, 2025 | Barclays | Equal-Weight | Maintains | $N/A | |
| Nov 6, 2025 | TD Cowen | Hold | Maintains | $N/A | |
| Oct 21, 2025 | Citigroup | Buy | Maintains | $N/A | |
| Oct 16, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A |
Array Technologies Inc. (ARRY) Competitors
The following stocks are similar to Array BioPharma based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ARRY
Array BioPharma
mkt cap
1.40B
Array Technologies Inc. (ARRY) Financial Data
Array Technologies Inc. has a market capitalization of $1.24B with a P/E ratio of 61.9x. The company generates $1.21B in trailing twelve-month revenue with a -5.6% profit margin.
Revenue growth is -26.1% quarter-over-quarter, while maintaining an operating margin of +2.0% and return on equity of -22.6%.
Valuation Metrics
Market Cap
$1.24B
Enterprise Value
$2.39B
P/E Ratio
61.9x
PEG Ratio
-0.1x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
-26.1%
Gross Margin
+28.2%
Operating Margin
+2.0%
Net Margin
-5.6%
EPS Growth
-88.1%
Financial Health
Cash/Price Ratio
+16.1%
Current Ratio
2.3x
Debt/Equity
284.9x
ROE
-22.6%
ROA
+3.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Array Technologies Inc. (ARRY) Business Model
About Array Technologies Inc.
What They Do
Manufactures solar tracking systems for energy projects.
Business Model
The company generates revenue by designing and supplying single-axis solar trackers that enhance the efficiency of solar energy production for utility-scale projects. It also offers engineering support and digital tools to optimize solar project design and installation, catering to firms involved in large solar power plants.
Additional Information
Array Technologies Inc. focuses on durable hardware and innovative design, which positions it well in the competitive renewable energy market. Its products are critical for engineering, procurement, and construction firms, as well as utility companies, making it an integral part of the solar energy value chain.
Company Information
Sector
Technology
Industry
Solar
Employees
1,200
CEO
Mr. Kevin G. Hostetler
Country
United States
IPO Year
2010
Website
arraytechinc.comArray Technologies Inc. (ARRY) Latest News & Analysis
Latest News
Quick Summary
ARRAY Technologies, Inc. has launched an enhanced version of its ARRAY OmniTrack® terrain-following tracker, featuring increased flex capability of up to 2° between adjacent posts.
Why It Matters
ARRAY Technologies' new enhanced OmniTrack® solar tracker could improve efficiency and reduce costs for solar projects, potentially boosting market share and revenue, making it attractive to investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Array Technologies, Inc. (ARRY) presented at the J.P. Morgan 54th Annual Global Technology, Media and Communications Conference.
Why It Matters
Array Technologies' presentation at a major conference signals potential growth opportunities, strategic insights, and market positioning, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Array Technologies, Inc. is rated a Buy with a $2.4B order backlog and strong growth potential. The APA Solar acquisition enhances its market position amid rising solar demand.
Why It Matters
Array Technologies' strong order backlog and favorable valuation metrics indicate potential growth, while the APA Solar acquisition enhances market position, driving future profitability.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
ARRAY Technologies will participate in several investor conferences in May and June, enhancing engagement with potential investors and stakeholders.
Why It Matters
ARRAY Technologies' participation in investor conferences signals potential growth opportunities and increased visibility, which could positively influence stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Array Technologies, Inc. (ARRY) held its Q1 2026 earnings call, discussing financial performance and operational updates. Further details on earnings and forecasts were provided during the call.
Why It Matters
Array Technologies' Q1 2026 earnings reveal financial performance and growth potential, impacting stock valuation and investor sentiment in the solar industry.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
The company has reached a record order book of $2.4 billion and launched the DuraTrack D2S™ for international markets.
Why It Matters
A record order book of $2.4 billion indicates strong demand and future revenue potential, while the introduction of DuraTrack D2S™ suggests growth opportunities in international markets.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ARRY Stock
What is Array Technologies Inc.'s (ARRY) stock forecast for 2026?
Based on our analysis of 16 Wall Street analysts, Array Technologies Inc. (ARRY) has a median price target of $10.00. The highest price target is $16.00 and the lowest is $8.00.
Is ARRY stock a good investment in 2026?
According to current analyst ratings, ARRY has 13 Buy ratings, 11 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.09. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ARRY stock?
Wall Street analysts predict ARRY stock could reach $10.00 in the next 12 months. This represents a 23.6% increase from the current price of $8.09. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Array Technologies Inc.'s business model?
The company generates revenue by designing and supplying single-axis solar trackers that enhance the efficiency of solar energy production for utility-scale projects. It also offers engineering support and digital tools to optimize solar project design and installation, catering to firms involved in large solar power plants.
What is the highest forecasted price for ARRY Array Technologies Inc.?
The highest price target for ARRY is $16.00 from at , which represents a 97.8% increase from the current price of $8.09.
What is the lowest forecasted price for ARRY Array Technologies Inc.?
Price targets from Wall Street analysts for ARRY are not currently available. The stock is trading at $8.09.
What is the overall ARRY consensus from analysts for Array Technologies Inc.?
The overall analyst consensus for ARRY is bullish. Out of 16 Wall Street analysts, 13 rate it as Buy, 11 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are ARRY stock price projections?
Stock price projections, including those for Array Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 6, 2026 3:18 PM UTC